These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 451349)
21. Tranylcypromine lowers human platelet MAO B activity but not concentration. Fritz RR; Malek-Ahmadi P; Rose RM; Denney RM; Abell CW Biol Psychiatry; 1983 Jun; 18(6):685-94. PubMed ID: 6871302 [TBL] [Abstract][Full Text] [Related]
22. Monoamine oxidase (MAO) of platelets, plasma, lymphocytes and granulocytes in schizophrenia. Bond PA; Cundall RL; Falloon IR Br J Psychiatry; 1979 Apr; 134():360-5. PubMed ID: 444786 [TBL] [Abstract][Full Text] [Related]
24. Biological and behavioral consequences of alterations in monoamine oxidase activity. Murphy DL; Kalin NH Schizophr Bull; 1980; 6(2):355-67. PubMed ID: 6103577 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the uptake of various amines into storage vesicles of intact human platelets. Costa JL; Murphy DL; Reveille J Br J Pharmacol; 1977 Oct; 61(2):223-8. PubMed ID: 922252 [TBL] [Abstract][Full Text] [Related]
27. [The role of monoamine oxidase in the regulation of mitochondrial energy functions]. Medvedev AE; Gorkin VZ Vopr Med Khim; 1991; 37(5):2-6. PubMed ID: 1759390 [TBL] [Abstract][Full Text] [Related]
28. Urinary acid metabolites of biogenic amines in schizophrenic patients. Domino EF Schizophr Bull; 1980; 6(2):238-44. PubMed ID: 6154967 [TBL] [Abstract][Full Text] [Related]
29. Endogenous modulation of monoamine oxidase in schizophrenic and normal humans. Becker RE; Giambalvo CT Am J Psychiatry; 1982 Dec; 139(12):1567-70. PubMed ID: 7149055 [TBL] [Abstract][Full Text] [Related]
30. Investigation of some biological trait markers in migraine: deuterated tyramine challenge test, monoamine oxidase, phenolsulfotransferase and plasma and urinary biogenic amine and acid metabolite levels. Davis BA; Dawson B; Boulton AA; Yu PH; Durden DA Headache; 1987 Jul; 27(7):384-9. PubMed ID: 3477534 [No Abstract] [Full Text] [Related]
31. Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase. Murphy DL; Sims KB; Karoum F; de la Chapelle A; Norio R; Sankila EM; Breakefield XO J Neurochem; 1990 Jan; 54(1):242-7. PubMed ID: 2293615 [TBL] [Abstract][Full Text] [Related]
33. Effect of hyper- and hypothyroidism on platelet monoamine oxidase activity and serotonin metabolism. Feldman JM; Roche J Metabolism; 1977 Jun; 26(6):657-64. PubMed ID: 859446 [TBL] [Abstract][Full Text] [Related]
34. Monoamine oxidase: studies of normal and psychiatric populations in a tropical environment. Sengupta N; Datta SC; Sengupta D Enzyme; 1981; 26(4):191-200. PubMed ID: 7250095 [TBL] [Abstract][Full Text] [Related]
35. Effect of metastatic cancer on platelet monoamine oxidase activity and serotonin metabolism. Feldman JM Cancer; 1979 Nov; 44(5):1751-6. PubMed ID: 498046 [TBL] [Abstract][Full Text] [Related]
36. The effect of adrenaline on human platelet MAO activity. Gentil V; Greenwood MH; Lader MH Psychopharmacologia; 1975 Oct; 44(2):187-90. PubMed ID: 1105633 [TBL] [Abstract][Full Text] [Related]
38. Platelet monoamine oxidase activity and plasma levels of non-catecholic phenylethylamines in insulin-dependent diabetic subjects. Mosnaim AD; Karoum F; Zeller A; Callaghan OH; Singh SP; Wolf ME Clin Chim Acta; 1982 Dec; 126(3):237-42. PubMed ID: 6758984 [TBL] [Abstract][Full Text] [Related]
39. Effects of fluorostigmine, toxogonin and atropine on monoamine oxidase activity and the level of biogenic amines in mouse brain. Kleinrok Z; Jagiełło-Wójtowicz E; Sieklucka-Dziuba M Acta Physiol Pol; 1979; 30(4):437-44. PubMed ID: 388982 [TBL] [Abstract][Full Text] [Related]